April 6, 2022
April 6, 2022 —
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
August 15, 2012
August 15, 2012 —
An international team of researchers has found that certain bioactive components found in human milk are associated with a reduced risk of HIV transmission from an HIV infected mother to her breast-fed infant. Their study will be published in the August 15 online edition of American Journal of Clinical Nutrition.
May 9, 2018
May 9, 2018 —
In a new paper, an international team led by scientists at University of California San Diego School of Medicine describe successfully grafting induced pluripotent stem cell (iPSC)-derived neural precursor cells back into the spinal cords of genetically identical adult pigs with no immunosuppression efforts. The grafted cells survived long-term, displayed…
February 18, 2016
February 18, 2016 —
…Bruce Beutler is an immunologist, geneticist and a professor and director of the Center for Genetics of Host Defense at the University of Texas Southwestern Medical Center. He received the 2011 Nobel Prize in Physiology or Medicine with Jules Hoffman for their discoveries surrounding the activation of innate immunity. Photo…
June 6, 2017
June 6, 2017 —
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
November 30, 2016
November 30, 2016 —
On November 4, 2016, surgeons at UC San Diego Health performed the region’s first combined heart-liver transplant (CHLT). During the 10-hour surgery, 54-year old Frank “Sonny” Taitano received a healthy heart and liver. This is the first successful heart-liver transplant for San Diego; less than 10 of these surgeries are…